Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial-Reference-Cited by-同舟云学术

Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial

Published:2018-08-14 Issue:6 Volume:27 Page:465-470
ISSN:1055-0496
Container-title:The American Journal on Addictions
language:en
Short-container-title:Am J Addict

Author:

Campbell Aimee N. C.¹^ORCID,Barbosa-Leiker Celestina²,Hatch-Maillette Mary³,Mennenga Sarah E.⁴,Pavlicova Martina⁵,Scodes Jennifer¹,Saraiya Tanya⁶,Mitchell Shannon G.⁷,Rotrosen John⁴,Novo Patricia⁴,Nunes Edward V.¹,Greenfield Shelly F.⁸

Affiliation:

1. Department of Psychiatry and New York State Psychiatric Institute; Columbia University Medical Center; New York New York

2. College of Nursing; Washington State University; New York New York

3. Department of Psychiatry & Behavioral Sciences; Alcohol and Drug Abuse Institute; University of Washington; Seattle Washington

4. Department of Psychiatry; New York University School of Medicine; New York New York

5. Department of Biostatistics; Columbia University Mailman School of Public Health; New York New York

6. Derner School of Psychology; Adelphi University; Garden City New York

7. Friends Research Institute, Inc.; Baltimore Maryland

8. Harvard Medical School Department of Psychiatry and McLean Hospital; Boston Massachusetts

Funder

National Institute on Drug Abuse

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajad.12784/fullpdf

Reference10 articles.

1. 2015

2. 2013 http://www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses/index.html

3. 2017 http://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-gender/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D

4. Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial;Back;Am J Drug Alcohol Abuse,2011

5. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial;Lee;Lancet,2018

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The co-creation and evaluation of a recovery community center bundled model to build recovery capital through the promotion of reproductive health and justice;Addiction Research & Theory;2023-12-13

2. Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims;Drug and Alcohol Dependence Reports;2023-12

3. Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder;The American Journal on Addictions;2023-08-15

4. The State of the Research on Opioid Outcomes Among Lesbian, Gay, Bisexual, Transgender, Queer, and Other Sexuality- and Gender-Diverse Populations: A Scoping Review;LGBT Health;2023-01-01

5. The Impact of Individual Counseling on Treatment for Opioid Use;Journal of Addictions Nursing;2022-10